EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $103M invested in ESSA Pharma in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
83% less call options, than puts
Call options by funds: $27K | Put options by funds: $159K
Holders
36
Holding in Top 10
–
Calls
$27K
Puts
$159K
Top Buyers
| 1 | +$966K | |
| 2 | +$263K | |
| 3 | +$143K | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$42.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$32.7K |
Top Sellers
| 1 | -$246K | |
| 2 | -$180K | |
| 3 | -$78.5K | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$76.4K |
| 5 |
State Street
Boston,
Massachusetts
|
-$65.9K |